comparemela.com

Latest Breaking News On - Fosun diagnostics - Page 2 : comparemela.com

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

/PRNewswire/ April 13, 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH, 02196.HK) announced that.

United statesFosun pharmaCouncil of chinaSinopharm co ltdShanghai fosun pharmaceutical group co ltdEuropean unionSolutions for covidEu health security committee common listSecurity committee common listState councilJoint preventionCoronavirus antigen detection application planPilot trialIndependent innovationProviding comprehensive solutionsFosun diagnostics

Fosun Diagnostics Obtains China Approval for SARS-CoV-2 Antigen Test

The kit detects the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs within seven days of infection for patients with respiratory and fever symptoms.

Fosun pharmaChina national medical products administrationEuropean unionInstitute for drugsShanghai fosun pharmaceuticalNational medical products administrationFosun diagnosticNovel coronavirusAntigen detection kitColloidal goldFosun diagnosticsFederal instituteMedical devicesFosun diagnostic novel coronavirus

Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively

The Proportion of Revenue from Innovative Products Continues to Increase Highlights: Revenue for the year ended December 31, 2021 was RMB39,005 million,.

South sudanUnited statesHong kongHan li kang rituximabYi baoWanbang biopharmYao pharmaWu yifangFosun pharmaAxicabtagene ciloleucelGuilin pharmaXin avatrombopagHan li kangSinopharm co ltdShanghai fosun pharmaceutical group co ltdVaccines division

vimarsana © 2020. All Rights Reserved.